VI
VivoSim Labs, Inc. (VIVS)
NASDAQ·Healthcare·Biotechnology
$1.44
-4.00%
Mkt Cap $4.88M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 11, 2026 | $50.00K | $26.00K | -48.00% | -$2.40 | -$1.03 | +57.08% | — | — |
| Q4 2025 Nov 6, 2025 | $50.00K | $28.00K | -44.00% | -$2.28 | -$0.98 | +57.02% | — | — |
| Q3 2025 Aug 12, 2025 | — | $37.00K | — | — | -$1.14 | — | — | — |
| Q2 2025 May 30, 2025 | — | $51.00K | — | -$2.28 | -$3.48 | -52.63% | — | — |
| Q4 2024 Nov 8, 2024 | — | $30.00K | — | -$0.26 | -$0.14 | +46.15% | — | — |
| Q2 2024 Jun 30, 2024 | — | $39.00K | — | — | -$2.74 | — | — | — |
| Q1 2024 Mar 31, 2024 | — | $29.00K | — | — | -$3.07 | — | — | — |
| Q4 2023 Dec 31, 2023 | — | $5.00K | — | — | -$4.74 | — | — | — |
| Q3 2023 Sep 30, 2023 | — | — | — | — | -$5.50 | — | — | — |
| Q2 2023 Jun 30, 2023 | — | $75.00K | — | — | -$5.54 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | $162.00K | — | — | -$10.27 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | $131.00K | — | — | -$4.50 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | $77.00K | — | — | -$4.57 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$4.43 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | $1.50M | — | — | -$2.63 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$4.82 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$4.83 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$3.49 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$3.99 | — | — | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$4.39 | — | — | — |